Expert consensus on clinical trials of preventive treatment of adult migraine in China / 中华内科杂志
Chinese Journal of Internal Medicine
;
(12): 494-506, 2023.
Artigo
em Chinês
| WPRIM
| ID: wpr-981047
ABSTRACT
Migraine is the most common disabling primary headache with a significant socioeconomic burden. At present, some emerging drugs for migraine preventive treatment are under investigation internationally, which significantly promote the progress of migraine treatment. However, only few of this trial for migraine treatment are explored in China. In order to promote and standardize controlled clinical trials of migraine preventive therapy in China, and to provide methodological guidance for the design, implementation and evaluation of clinical trials, the Headache Collaborators of Chinese Society of Neurology formulated this consensus.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
China
/
Consenso
/
Cefaleia
/
Transtornos de Enxaqueca
/
Neurologia
Limite:
Adulto
/
Humanos
País/Região como assunto:
Ásia
Idioma:
Chinês
Revista:
Chinese Journal of Internal Medicine
Ano de publicação:
2023
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS